Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Nomax, INC | Saint Louis, MO, United States | Makes it | Problems found, fixed voluntarilyDec 2, 2022 · 6 inspections |
Recalls
- Apr 19, 2024 · Class II · Nomax Inc
Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Lots: Lot #: 14708, Exp. 04/30/2024.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Fluorescein: every company that makes it
- Form
- strip, ophthalmic
- Strength
- 1 mg
- Approval
- UNAPPROVED DRUG OTHER
- On the market since
- Jul 30, 2013
- Package NDCs
51801-009-4051801-009-50- Official label
- DailyMed (National Library of Medicine), updated Dec 23, 2019
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?